{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:46:26Z","timestamp":1787013986023,"version":"build-2736575974"},"reference-count":40,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["1003\u2010215S011"],"award-info":[{"award-number":["1003\u2010215S011"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Chem Biol Drug Des"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Viral infections are a global cause of serious morbidity and mortality. The recent COVID\u201019 pandemic further testifies to the continued need to develop novel classes of antiviral agents with broad activity and high selectivity. In this work, 5\u2010(trifluoromethoxy)\u20101\n                    <jats:italic>H<\/jats:italic>\n                    \u2010indole\u20102,3\u2010dione 3\u2010(4\u2010phenylthiosemicarbazones) bearing a methyl or ethyl group at position 1\u2010 of the indole ring were synthesized. Along with previously synthesized compounds\n                    <jats:bold>5a\u2010j<\/jats:bold>\n                    ,\n                    <jats:bold>5l<\/jats:bold>\n                    ,\n                    <jats:bold>6b\u2010d<\/jats:bold>\n                    ,\n                    <jats:bold>6g<\/jats:bold>\n                    ,\n                    <jats:bold>6i<\/jats:bold>\n                    , and\n                    <jats:bold>6k\u2010n<\/jats:bold>\n                    , the novel compounds\n                    <jats:bold>5k<\/jats:bold>\n                    ,\n                    <jats:bold>6a<\/jats:bold>\n                    ,\n                    <jats:bold>6e<\/jats:bold>\n                    ,\n                    <jats:bold>6f<\/jats:bold>\n                    ,\n                    <jats:bold>6h<\/jats:bold>\n                    ,\n                    <jats:bold>6j<\/jats:bold>\n                    , and\n                    <jats:bold>6o<\/jats:bold>\n                    were evaluated in cytopathic effect (CPE) reduction assays with a broad range of DNA and RNA viruses. Favorable activity was observed in human embryonic lung (HEL) fibroblast cells infected with herpes simplex virus type 1 (HSV\u20101, wild type or thymidine kinase\u2010deficient) and type 2, or with vaccinia virus (VV). In general, the ethyl substituted compounds (\n                    <jats:bold>6a\u2013o<\/jats:bold>\n                    ) had higher antiviral activity and lower cytotoxicity than the methyl substituted analogues (\n                    <jats:bold>5a\u2013l<\/jats:bold>\n                    ). The antiviral potency was markedly enhanced by substitution at position 4\u2010 of the phenyl ring, with the analogues bearing a 4\u2010methyl (\n                    <jats:bold>6c<\/jats:bold>\n                    ), 4\u2010fluoro (\n                    <jats:bold>6l<\/jats:bold>\n                    ), or 4\u2010chloro (\n                    <jats:bold>6n<\/jats:bold>\n                    ) moiety exhibiting average EC\n                    <jats:sub>50<\/jats:sub>\n                    values of 1.6 to 6.6\u2009\u03bcM against HSV\u20101, HSV\u20102, and VV, besides selectivity indices (i.e., ratio of cytotoxic over antiviral concentration) of 21\u201340. Within the series bearing a substituent at position 3\u2010, the trifluoromethyl analogue\n                    <jats:bold>6d<\/jats:bold>\n                    was unique in suppressing human adenovirus type 2 (AdV\u20102) and coronavirus HCoV\u2010229E. To conclude, our study highlights the versatility and relevance of the 5\u2010(trifluoromethoxy)\u20101\n                    <jats:italic>H<\/jats:italic>\n                    \u2010indole\u20102,3\u2010dione 3\u2010(4\u2010phenylthiosemicarbazones) for developing antiviral agents against different virus families.\n                  <\/jats:p>","DOI":"10.1111\/cbdd.70259","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T11:57:56Z","timestamp":1770119876000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["From Synthesis to Efficacy: Synthesis, Structural Analysis, and Antiviral Activity of 5\u2010(Trifluoromethoxy)\u2010\n                    <scp>\n                      1\n                      <i>H<\/i>\n                    <\/scp>\n                    \u2010indole\u20102,3\u2010dione 3\u2010Thiosemicarbazones"],"prefix":"10.1111","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8875-3522","authenticated-orcid":false,"given":"\u00d6zge","family":"Soylu\u2010Eter","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy Istanbul University  Istanbul Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leentje","family":"Persoons","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology, and Transplantation KU Leuven, Rega Institute for Medical Research  Leuven Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9742-9302","authenticated-orcid":false,"given":"Lieve","family":"Naesens","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology, and Transplantation KU Leuven, Rega Institute for Medical Research  Leuven Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilg\u00fcn","family":"Karal\u0131","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy Istanbul University  Istanbul Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00706\u2010013\u20101034\u20103"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2023.08.003"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc\u20102023\u20100179"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199904223401608"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476\u20105381.1960.tb01216.x"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2025.106152"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2009.03.043"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.poly.2005.05.021"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.4.2265"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2023.2234665"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00044\u2010021\u201002832\u20104"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph16091247"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/00397919808006872"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.17344\/acsi.2023.8589"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2008.08.050"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.3181\/00379727\u201073\u201017652\/PDF"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm9014394"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2011.02.037"},{"key":"e_1_2_10_20_1","unstructured":"Karali N. P.Eraslan\u2010Elma G.Cihan\u2010\u00dcst\u00fcnda\u011f andF.G\u00f6kta\u015f.2015.\u201cNew 1\u2010Substituted 1H\u2010Indole\u20102 3\u2010Dione Compounds ve Synthesis Methods Turkish Patent Applications TR 2015 015912 B.\u201d"},{"key":"e_1_2_10_21_1","unstructured":"Karali N. F.G\u00f6kta\u015f G.Cihan\u2010\u00dcst\u00fcnda\u011f andP.Eraslan\u2010Elma.2017.\u201cN\u2010[(Aminosulfonyl)phenyl]\u20102\u2010(1 2\u2010Dihydro\u20102\u2010Oxo\u20103H\u2010Indol\u20103\u2010Ylidene)hydrazinecarbothioamide Derivatives for Treating Cancer and Immunological Disorders. PCT International Applications WO 2017 099695 A1.\u201d"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.589"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112702"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749\u20106632.1977.tb21942.x"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2024.110063"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm049147h"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1135\/cccc19861692"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.4.2270"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2014.05.044"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.104202"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.055921\u20100"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.26650\/IstanbulJPharm.2020.0080"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202300217"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tet.2004.08.030"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1023\/B:RUJO.0000044552.07729.40"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm0704189"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/S41579\u2010020\u201000468\u20106"},{"key":"e_1_2_10_38_1","unstructured":"WHO.2024.\u201cHerpes Simplex Virus.\u201dhttps:\/\/www.who.int\/news\u2010room\/fact\u2010sheets\/detail\/herpes\u2010simplex\u2010virus."},{"key":"e_1_2_10_39_1","unstructured":"WHO Data.2024.\u201cWHO COVID\u201019 Dashboard.\u201dhttps:\/\/data.who.int\/dashboards\/covid19\/deaths?n=o."},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.54.3.946"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2022.105799"}],"container-title":["Chemical Biology &amp; Drug Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cbdd.70259","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cbdd.70259","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cbdd.70259","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T11:55:13Z","timestamp":1775994913000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cbdd.70259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1111\/cbdd.70259"],"URL":"https:\/\/doi.org\/10.1111\/cbdd.70259","archive":["Portico"],"relation":{},"ISSN":["1747-0277","1747-0285"],"issn-type":[{"value":"1747-0277","type":"print"},{"value":"1747-0285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"2025-08-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70259"}}